To data, there have been 13 reported injuries. Becton Dickinson (BD)/Carefusion 303 is recalling the Alaris infusion pump due to incompatibility issues with Cardinal Health Monoject syringes. The Food ...
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. BD has expanded a Class I Alaris recall to cover 15 ...
FILE PHOTO: Signage is seen outside of FDA headquarters in White Oak, Maryland (Reuters) -The U.S. Food and Drug Administration (FDA) said on Friday that Becton Dickinson is recalling its Alaris ...
The U.S. FDA said that BD (NYSE:BDX) has expanded its Class I voluntary recall to inform customers about the worst-case performance of the BD Alaris Pump Module model 8100 when used with certain ...
Please provide your email address to receive an email when new articles are posted on . The FDA granted 510(k) clearance to Becton Dickinson’s updated Alaris infusion pump, allowing the company to ...